In the phase 3 PANOVA-3 trial, patients who underwent tumor-treating fields therapy had extended overall survival vs standard ...

OpenAI’s newest creation, the o3 model—billed as their “smartest and most capable to date”—rebelled against direct commands ...

Avery Thomas begins her day bright and early at 8 a.m. at El Camino College. With deadlines in mind, she knows she might have ...

Researchers reveal that Merkel cell polyomavirus bypasses normal nuclear entry routes by exploiting the temporary breakdown ...

Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Michael Hofman presented an in-depth ...